First AD

Second AD

Unmet Needs in CSU Management

Video content above is prompted by the following:

What are the unmet needs in CSU management? How is the field evolving?

Evolving Perspectives and Treatment Strategies in Chronic Spontaneous Urticaria 

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Chronic spontaneous urticaria (CSU) management faces several unmet needs, including the need for more effective treatments and better understanding of disease mechanisms. Current therapies often fail to provide complete symptom relief, and there is a significant demand for novel therapeutic options. The field is evolving with advancements in biologics and personalized medicine approaches, aiming to improve patient outcomes. Research is focusing on identifying biomarkers for better diagnosis and treatment stratification. Additionally, there is an emphasis on improving patient quality of life through comprehensive management strategies.

Panelists discuss the unmet needs in chronic spontaneous urticaria (CSU) management, highlighting the evolution of the field toward more personalized and effective treatment strategies to address refractory symptoms.

Bringing CSU Back Under The House of Dermatology

Understanding the Chronicity of CSU

The Psychosocial Impact of CSU

The Pathogenesis of CSU

Tips on Diagnosing CSU

Less Is More: Diagnostic Testing for CSU

Disease Severity and Delays in Treatment in CSU

The Role of Dermatologists in Treating CSU

Treatment Approaches and the Limitations of Antihistamines for CSU

Steroids and Immunosuppressive Agents for CSU

Novel Therapeutics in Development for CSU

The Role of BTK Inhibition in CSU

The Importance of Patient Education and Shared Decision-Making in CSU

The Role of BTK Inhibitors in the Evolving CSU Treatment Landscape

Key Takeaways and Future Directions in CSU Care